You are here

Molecular Imaging


For all the challenges faced by preterm babies, limited research explores how birth early in the third trimester can affect hearing and understanding speech. A team of researchers, using MRI, found children born prematurely were more likely to face speech and language problems by the age of 2.

According to a recent National Institutes of Health (NIH) press release, new research suggests that genetic variations in the lungs can differentiate between individuals who have stably low lung function early in life (that steadily declines with age) versus those who are at risk for chronic obstructive pulmonary disease (COPD) due to smoking.  

Researchers from the Chinese University of Hong Kong and Ann & Robert H. Lurie Children's Hospital of Chicago have two types of technology to predict how well a deaf child can learn language after receiving cochlear implant surgery. 

A team of researchers has proven a new radiotracer, 2-18F-fluorodeoxysorbitol (18F-FDS), more adept at tracking bacterial infection in lungs than current imaging methods, while also distinguishing bacterial infection from inflammation.

Head trauma and sports—most notably football but also hockey, soccer and boxing—have been the focus of plenty of media coverage. Recent studies have shown an overwhelming majority of deceased football player’s brains contained evidence of chronic traumatic encephalopathy, or CTE.


Recent Headlines

Can you drink too much water? fMRI research says you can

Many of us struggle to drink the recommended eight glasses of water per day, but a new study suggests that we're not supposed to.

Q&A: Katrina Pitas on the NNSA, producing Mo-99 and the future of SHINE Medical Technologies

Katrina Pitas, vice president of business development for SHINE Medial Technologies, is in St. Louis this week to speak at the 2016 Mo-99 Topical Meeting. While preparing for her presentation, she spoke with Health Imaging about what SHINE has been up to this year and what she will be discussing at the meeting. 

Mallinckrodt to sell nuclear medicine business to IBA Molecular for $690 million

Mallinckrodt Pharmaceuticals announced Aug. 24 it has reached an agreement to sell its nuclear imaging business to IBA Molecular (IBAM) for $690 million.

Scientists utilize RNA to map neural networks

An innovative use of RNA sequences has allowed scientists from Cold Spring Harbor Laboratory to track connections between individual neurons in the brain, according to a study published in Neuron. Invented by Professor Anthony Zador, MD, PhD, the technique is called Multiplexed Analysis of Projections by Sequencing (MAPseq). 

MRIs show Parkinsonian diseases cause unique decline in functional brain activity

A new study allowed researchers to get a look at the way Parkinson’s disease patients’ brains changed over the course of a year through functional MRI scans. The changes observed through fMRI scans of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) patients’ and healthy controls’ brains were different across the groups.

Mediterranean diet may delay Alzheimer's

There’s a mountain of evidence showing that the traditional Mediterranean diet reduces the risk of heart disease, but a new UCLA study suggests that it can slow the progression of Alzheimer’s as well.

Researchers view live synapse formation for the first time

Researchers have designed a method to visualize the formation of new synapses in mice using photon imaging, according to a study published in the August issue of Science. The technique could uncover information critical to developing new therapies for developmental disorders, according to co-author Hyung-Bae Kwon, PhD.

Study pinpoints region of the brain heavily affected by Parkinson's

Researchers have pinpointed regions in the brain that are affected by Parkinson’s disease, opening the door to a potential treatment.

Image-based predictor of dementia in patients with Down syndrome

Neural biomarkers could be used to predict the risk for dementia in individuals with Down Syndrome, according to a University of Kentucky study.

First imaging of brain epigenetics achieved with new PET radiochemical

Harvard researchers have developed a novel PET radiotracer that can reveal genetic expression, or lack thereof, in the brain enzymes called histone deacetylases (HDACs).